Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Hilltop National Bank

Hilltop National Bank lessened its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) by 5.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 436 shares of the medical equipment provider’s stock after selling 25 shares during the quarter. Hilltop National Bank’s holdings in Intuitive Surgical were worth $228,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently bought and sold shares of the business. Godsey & Gibb Inc. grew its stake in shares of Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares during the period. MidAtlantic Capital Management Inc. acquired a new stake in shares of Intuitive Surgical during the 3rd quarter worth approximately $33,000. Mark Sheptoff Financial Planning LLC acquired a new stake in shares of Intuitive Surgical during the 2nd quarter worth approximately $37,000. Capital Performance Advisors LLP acquired a new stake in shares of Intuitive Surgical during the 3rd quarter worth approximately $38,000. Finally, DT Investment Partners LLC grew its stake in Intuitive Surgical by 80.0% in the 3rd quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock valued at $40,000 after acquiring an additional 36 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analysts Set New Price Targets

ISRG has been the topic of a number of research analyst reports. Royal Bank of Canada lifted their price target on shares of Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research note on Friday, October 18th. Piper Sandler reissued an “overweight” rating and issued a $538.00 price target (up previously from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. Citigroup lifted their price target on shares of Intuitive Surgical from $567.00 to $640.00 and gave the company a “buy” rating in a research note on Wednesday, December 11th. Mizuho raised their price objective on Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Finally, Robert W. Baird lifted their target price on shares of Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research note on Thursday, October 17th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $554.17.

Get Our Latest Analysis on Intuitive Surgical

Insiders Place Their Bets

In related news, CFO Jamie Samath sold 270 shares of the company’s stock in a transaction that occurred on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total transaction of $145,840.50. Following the sale, the chief financial officer now directly owns 8,757 shares in the company, valued at approximately $4,730,093.55. This represents a 2.99 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Brian Edward Miller sold 2,553 shares of the company’s stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,314,795.00. Following the sale, the executive vice president now owns 7,066 shares in the company, valued at $3,638,990. The trade was a 26.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 48,190 shares of company stock worth $25,012,927 over the last three months. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $547.47 on Friday. The firm’s 50-day moving average is $535.93 and its two-hundred day moving average is $494.44. Intuitive Surgical, Inc. has a 12 month low of $355.17 and a 12 month high of $556.23. The stock has a market capitalization of $195.00 billion, a P/E ratio of 88.02, a PEG ratio of 5.31 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRGGet Free Report) last posted its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. The company had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. As a group, analysts anticipate that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

About Intuitive Surgical

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Featured Articles

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.